Progyny, Inc. Fair Value Adjustment of Warrants
Progyny, Inc. (PGNY) reported Fair Value Adjustment of Warrants of $5.76 million for the 3-month period ending 2019-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-03-01
- Progyny, Inc. fair value adjustment of warrants for the quarter ending 2019-12-31 was $5.76M, a 316.27% increase year-over-year.
- Progyny, Inc. fair value adjustment of warrants for the quarter ending 2019-09-30 was $11.23M, a 1122.88% increase year-over-year.
- Progyny, Inc. fair value adjustment of warrants for the quarter ending 2019-06-30 was $642.00K, a 39.87% increase year-over-year.
- Progyny, Inc. fair value adjustment of warrants for the quarter ending 2019-03-31 was $551.00K, a 199.46% increase year-over-year.
- Progyny, Inc. fair value adjustment of warrants for fiscal 2019 was $18.18M, a 517.39% increase from fiscal 2018.
- Progyny, Inc. fair value adjustment of warrants for fiscal 2018 was $2.94M, a 312.32% increase from fiscal 2017.
- Progyny, Inc. fair value adjustment of warrants for fiscal 2017 was $714.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | $5.76M 10-K · filed 2021-03-01 | $16.98M derived: sum of 2 quarters · filed 2021-03-01 | $17.63M derived: sum of 3 quarters · filed 2021-03-01 | $18.18M 10-K · filed 2022-03-01 |
| 2019-09-30 | $11.23M 10-K · filed 2021-03-01 | $11.87M derived: sum of 2 quarters · filed 2021-03-01 | $12.42M 10-Q · filed 2020-11-06 | $13.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $642.00K 10-K · filed 2021-03-01 | $1.19M 10-Q · filed 2020-08-07 | $2.58M derived: sum of 3 quarters · filed 2021-03-01 | $3.49M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $551.00K 10-K · filed 2021-03-01 | $1.93M derived: sum of 2 quarters · filed 2021-03-01 | $2.85M derived: sum of 3 quarters · filed 2021-03-01 | $3.31M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $1.38M 10-K · filed 2020-03-10 | $2.30M derived: sum of 2 quarters · filed 2020-03-10 | $2.76M derived: sum of 3 quarters · filed 2020-03-10 | $2.94M 10-K · filed 2021-03-01 |
| 2018-09-30 | $918.00K 10-K · filed 2020-03-10 | $1.38M derived: sum of 2 quarters · filed 2020-03-10 | $1.56M 10-Q · filed 2019-12-06 | |
| 2018-06-30 | $459.00K 10-K · filed 2020-03-10 | $643.00K derived: sum of 2 quarters · filed 2020-03-10 | ||
| 2018-03-31 | $184.00K 10-K · filed 2020-03-10 | |||
| 2017-12-31 | $714.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |